Gb Sciences Inc financial data

Symbol
GBLX on OTC
Location
6450 Cameron Street #110 A, Las Vegas, NV
State of incorporation
Nevada
Fiscal year end
March 31
Former names
Growblox Sciences, Inc. (to 5/12/2017), Signature Exploration & Production Corp. (to 5/9/2014), Diabetic Treatment Centers of America, Inc. (to 3/6/2008), FLAGSTICK VENTURES INC (to 8/5/2004)
Latest financial report
10-K - Q1 2024 - Aug 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.61 % -60.2%
Debt-to-equity -104 % +31.2%
Return On Equity 27.9 % -84.2%
Return On Assets -763 % -185%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 407M shares
Common Stock, Shares, Outstanding 406M shares +6.34%
Entity Public Float 4M USD -64.6%
Common Stock, Value, Issued 40.7K USD +6.64%
Weighted Average Number of Shares Outstanding, Basic 397M shares
Weighted Average Number of Shares Outstanding, Diluted 379M shares +10.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Cost of Revenue 0 USD
General and Administrative Expense 1.58M USD -0.84%
Operating Income (Loss) -1.42M USD +15.1%
Nonoperating Income (Expense) 58.8K USD +95.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.36M USD +67%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -1.36M USD +67%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12K USD -89.1%
Assets, Current 103K USD -66.6%
Property, Plant and Equipment, Net 0 USD -100%
Assets 103K USD -70.6%
Accounts Payable, Current 1.75M USD +0.92%
Accrued Liabilities, Current 0 USD -100%
Liabilities, Current 5.1M USD +7.06%
Liabilities 5.42M USD +13.8%
Retained Earnings (Accumulated Deficit) -110M USD -1.25%
Stockholders' Equity Attributable to Parent -5.31M USD -20.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -5.31M USD -20.6%
Liabilities and Equity 103K USD -70.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -105K USD +63.9%
Net Cash Provided by (Used in) Financing Activities 25K USD -77.7%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 950M shares 0%
Common Stock, Shares, Issued 406M shares +6.34%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -80.3K USD +55.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 110K USD -53%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 14.1M USD -2.97%
Deferred Tax Assets, Gross 14.1M USD -2.97%
Deferred Tax Assets, Operating Loss Carryforwards 11.1M USD +1.14%
Additional Paid in Capital 105M USD +0.43%
Amortization of Intangible Assets 624 USD -96.9%
Interest Expense 183K USD -32.7%